Drug resistance is a significant challenge in cancer treatment. Cancer cells can develop resistance to chemotherapy and targeted therapies, often through genetic mutations or adaptive responses that render treatments less effective. This resistance can lead to treatment failure and disease progression, necessitating the development of novel therapies and combination strategies to overcome resistance mechanisms.
